| Website | trinitybiosystems... |
| Category | BioTech |
| Phone | 650-566-0780 |
| busdev@trinitybio... | |
| Employees | |
| Founded | 2002 |
| TOTAL | $28.5M |
| FUNDING TOTAL | $28.5M |
| Series B, 7/06 Amgen Ventures Sanderling Ventures GSK Venture Fund Tenex Greenhouse Ventures | $21M |
| Venture Round, 11/09 Amgen Ventures Life Sciences Partners Lilly Ventures Sanderling Ventures SR One | $7.5M |
Trinity Biosystems, Inc. engages in the development and formulation of oral therapeutic proteins. It involves in developing vaccines in the areas of respiratory, digestive, and sexually transmitted diseases, as well as transporting proteins, peptides, and other macromolecules. The company was founded in 2002 and is based in Menlo Park, California.
